Ушбу иш иқтибос қилган ишлар

133 та иш

Иш: Breast cancer vaccines; A comprehensive and updated review

Current and future burden of breast cancer: Global statistics for 2020 and 2040
Melina Arnold, Eileen Morgan, Harriet Rumgay +8
Мақола20228 иқтибос
ABI
Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
Nida Iqbal, Nida Iqbal, Naveed Iqbal +1
Шарҳ мақола20146 иқтибос
ABI
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao +3
Шарҳ мақола20236 иқтибос
ABI
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Шарҳ мақола20184 иқтибос
ABI
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng, Mia Spezia, Shifeng Huang +15
Шарҳ мақола20184 иқтибос
ABI
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies, Edward W. Roberts, Kelly Kersten +15
Шарҳ мақола20184 иқтибос
ABI
CTLA-4 and PD-1 Pathways
Elizabeth I. Buchbinder, Anupam M. Desai
Шарҳ мақола20153 иқтибос
ABI
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani +4
Шарҳ мақола20233 иқтибос
ABI
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian +1
Шарҳ мақола20203 иқтибос
ABI
mRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J. Hogan, Frederick Porter +1
Шарҳ мақола20183 иқтибос
ABI
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Hans Raskov, Adile Orhan, Jan Pravsgaard Christensen +1
Шарҳ мақола20203 иқтибос
ABI
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
Marek Z. Wojtukiewicz, Magdalena M. Rek, Kamil Karpowicz +7
Шарҳ мақола20213 иқтибос
ABI
Targeting HER2-positive breast cancer: advances and future directions
Sandra M. Swain, Mythili Shastry, Erika Hamilton
Шарҳ мақола20223 иқтибос
ABI
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Шарҳ мақола20202 иқтибос
ABI
Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou, Ourania V. Beniata, Panagiotis Vitsos +2
Шарҳ мақола20162 иқтибос
ABI
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang +4
Шарҳ мақола20222 иқтибос
ABI
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
Matthew D. Vesely, Robert D. Schreiber
Мақола20132 иқтибос
ABI
Biological subtypes of breast cancer: Prognostic and therapeutic implications
Özlem Yersal
Шарҳ мақола20142 иқтибос
ABI
CD28 and CTLA‐4 coreceptor expression and signal transduction
Christopher E. Rudd, Alison Taylor, Helga Schneider
Шарҳ мақола20092 иқтибос
ABI
Targeted therapies in breast cancer: New challenges to fight against resistance
Viviana Masoud, Gilles Pagès
Шарҳ мақола20172 иқтибос
ABI
Ex vivo pulsed dendritic cell vaccination against cancer
Yangzhuo Gu, Xing Zhao, Xiangrong Song
Шарҳ мақола20202 иқтибос
ABI
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds +1
Шарҳ мақола20212 иқтибос
ABI
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou +3
Шарҳ мақола20212 иқтибос
ABI
Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors
Parnaz Merikhian, Behrad Darvishi, Neda Jalili +10
Мақола20212 иқтибос
ABI
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud +13
Шарҳ мақола20222 иқтибос
ABI